公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting | Reck M.; Garassino M.C.; Imbimbo M.; Shepherd F.A.; Socinski M.A.; JIN-YUAN SHIH ; Tsao A.; Lee P.; Winfree K.B.; Sashegyi A.; Cheng R.; Varea R.; Levy B.; Garon E. | Lung Cancer | 28 | 25 | |
2006 | Earnings forecast disclosure regulation and earnings management: Evidence from Taiwan IPO firms | Jaggi B.; Chin C.-L.; HSIOU-WEI W. LIN ; Lee P. | Review of Quantitative Finance and Accounting | |||
2016 | East Asian subgroup analysis of a randomized, double-blind, phase 3 study of docetaxel and ramucirumab versus docetaxel and placebo in the treatment of stage IV non-small cell lung cancer following disease progression after one prior platinum-based therapy (REVEL) | Park K.; Kim J.-H.; Cho E.K.; Kang J.-H.; JIN-YUAN SHIH ; Zimmermann A.H.; Lee P.; Alexandris E.; Puri T.; Orlando M. | Cancer Research and Treatment | 19 | 15 | |
2011 | A model to personalize scheduling of complex prescriptions | Wang T.-L.; Wu L.-C.; Huang Y.-J.; Lee P.; Chu T.-B.; Chung-Jung F.; DUAN-RUNG CHEN ; Yang M.-C.; Jian W.-S.; Li Y.-C. | Computer Methods and Programs in Biomedicine | 2 | 2 | |
2014 | An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer | Stadler W.M.; Vaughn D.J.; Sonpavde G.; Vogelzang N.J.; Tagawa S.T.; Petrylak D.P.; Rosen P.; CHIA-CHI LIN ; Mahoney J.; Modi S.; Lee P.; Ernstoff M.S.; Su W.-C.; Spira A.; Pilz K.; Vinisko R.; Schloss C.; Fritsch H.; Zhao C.; Carducci M.A. | Cancer | 78 | 73 | |
2021 | Practice effects, test–retest reliability, and minimal detectable change of the ruff 2 and 7 selective attention test in patients with schizophrenia | Lee P.; Li P.-C.; Liu C.-H.; Lin H.-Y.; CHIEN-YU HUANG ; CHING-LIN HSIEH | International Journal of Environmental Research and Public Health | 1 | 1 | |
2007 | A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine hydrochloride in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder | SUSAN SHUR-FEN GAU ; Huang Y.-S.; Soong W.-T.; Chou M.-C.; Chou W.-J.; CHI-YUNG SHANG ; Tseng, Wan-Ling; Allen A.J.; Lee P. | Journal of Child and Adolescent Psychopharmacology | 62 | 54 | |
2016 | Relative and Absolute Reliabilities of the Conners' Continuous Performance Test II in Schizophrenia | Lee P.; Lin H.-Y.; Liu C.-H.; Lu W.-S.; CHING-LIN HSIEH | Archives of Clinical Neuropsychology | 2 | 4 | |
2017 | Test-Retest Reliability and Minimal Detectable Change of the D2 Test of Attention in Patients with Schizophrenia | Lee P.; Lu W.-S.; Liu C.-H.; Lin H.-Y.; CHING-LIN HSIEH | Archives of Clinical Neuropsychology | 19 | 17 | |
2013 | The test-retest reliability and the minimal detectable change of the Purdue pegboard test in schizophrenia | Lee P.; Liu C.-H.; Fan C.-W.; Lu C.-P.; Lu W.-S.; CHING-LIN HSIEH | Journal of the Formosan Medical Association | 36 | 39 | |
2011 | Test-retest reliability of two attention tests in schizophrenia | Lee P.; Li P.-C.; Liu C.-H.; CHING-LIN HSIEH | Archives of Clinical Neuropsychology | 11 | 11 |